Member Info for Chelsea11

It would be fascinating to know how SCOPE recruitment is going.

From the Interims:

Second stage of SCOPE study in advanced melanoma with SCIB1 anticipated to complete recruitment in Q1 2024 with data available in Q3 2024.

· iSCIB1+ cohort of the SCOPE study to start recruitment in Q1 2024 with clinical data expected in Q3 2024.

Yes, Q3 is still some way off but the end of Q1 really isn’t that far away now.

New ISA year also approaching. I wonder if that might be on PI’s minds, given the upbeat Interims and published timelines. It’s on mine :-)

HAGW

The Betamax/VHS analogy wasn’t intended to provoke such deep analysis. Of course it’s not the same as medicine - that is bloomin obvious!

The point is a high-level one. What some folks strongly believe is the future, doesn’t always turn out to be the case.

Anyway, enough of these analogies. I have an appointment to get to, so it’s on with the Google Glasses and fire up the DeLorean.

Yep. That was a link to the Betamax conference.

The VHS conference is just around the corner :-)

CW - stripping out all the “big picture” waffle, earlier you posted that you hoped the need to attend big conferences like ASCO & AACR would diminish.

When I said that wouldn’t happen and they would continue to attend, even as the Company grows, you agreed with me.

Thanks for making your change of mind clear.

CW - “ Hopefully there time to impress and excplaining ground breaking , trailblazing , scientific in scientific posters, in large halls is diminishing !” (Said with reference to AACR & ASCO).

You really think that if Scancell were a multi-billion company in the future, they would not want or feel the need to attend these industry leading conferences??

Bojo- historic posts from CW with clear hostility towards Crumbs & Bermuda were also “very well put together”? Maybe you’ve forgotten those.

Btw - I’ve no issues with the 8:48 either.

Nothing interesting with the SP sub 12p!

Bermuda & Burble.

The Han Solo & Chewbacca of the Scancell board :-)

Simply unbeatable - thanks so much for all your wisdom and generosity in sharing it.

Makes wonder which product will actually turn out to be the Cullinan & Koh-i-Noor Diamonds in Lindy's Crown Jewels :-)

Seems they have woken up and smelt the scientists coffee.

Or is that smelled ;-)

“That’s the one that Genmab liked, moving forward into the the clinic, very exciting”

Antibodies at 26:20

Hey Burble.

Ciaskin kindly pasted a link yesterday.

https://vimeo.com/907889586/5d861ac47d?share=copy

Didn’t Lindy confirm in the presentation that Genmab WERE taking SC129 into the clinic and WERE very happy with it (or bullish words to that effect)?

I seem to recall that Berm (apols if not correct Berm), indicated some time back that that point in time, would typically be a development milestone to trigger a further payment in accordance with the type of deal in place.

Of course we don’t know how much that would be, nor precisely when it would be paid but given what Lindy said in the presentation, surely it’s reasonable to expect that payment to be made in the near term?

If that is confirmed via RNS inside the next couple of months, maybe the market will wake up to the commercial prospects here.

I can see that at the link below, it was last reviewed yesterday. Not sure if that means just reviewed (perhaps in connection with the presentation) and nothing updated, or something has been changed, or added?

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-SCIB1-pembrolizumab-advanced-melanoma#undefined

So refreshing to have a positive discussion on what Scancell are actually doing, rather than links to a magical mystery tour of the internet for anything cancer related.

Dracula - great presentation today, what do you want, blood?

Ciaskin - your choice of word “convincing” is bang on the money imo. Coming from both Lindy and Sath who I also thought was excellent.

Also an excellent Christmas Jumper Lindy was wearing.

Nothing negative today and won’t be in the presentation either and so another 46643 for me.

Thanks for clarification Burble. Appreciated.